MyAverix Finance
NS · Pharmaceuticals
Ind-Swift Laboratories Ltd (INDSWFTLAB)
Pharmaceuticals & Biotechnology
Ind-Swift Laboratories Ltd (INDSWFTLAB) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $16.75B, P/E ratio is 39.37, net margin is 26.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for INDSWFTLAB
Ind-Swift Laboratories Ltd (INDSWFTLAB) — FAQ
What is Ind-Swift Laboratories Ltd's market cap?
Ind-Swift Laboratories Ltd (INDSWFTLAB) has a reported market cap of $16.75B (data as of 2026-07-10).
What is INDSWFTLAB's P/E ratio?
The price-to-earnings (P/E) ratio for Ind-Swift Laboratories Ltd (INDSWFTLAB) is 39.37 (data as of 2026-07-10).
Does Ind-Swift Laboratories Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Ind-Swift Laboratories Ltd (INDSWFTLAB). Check the MyAverix Finance app for the latest dividend data.
What sector is Ind-Swift Laboratories Ltd in?
Ind-Swift Laboratories Ltd (INDSWFTLAB) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is INDSWFTLAB listed on?
INDSWFTLAB is listed on NS.
What is Ind-Swift Laboratories Ltd's net margin?
Ind-Swift Laboratories Ltd (INDSWFTLAB) reports a net margin of 26.6% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.